Microarrays & Multiplexing
News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to clinicians to help guide therapy in cancer patients.
Tumor Gene Expression Signature Linked to Chemotherapy Response in Colon Cancer Cases
Based on hundreds of stage II and III colon cancer samples, researchers uncovered and validated a 10-gene signature linked to adjuvant chemotherapy response.
Genomics Plc Shows Feasibility of Implementing Polygenic Risk Scores in Routine Clinical Care
Premium
Cardiovascular risk scores from a common tool and one with a PRS added correlated well with each other, with the added PRS impacting some care decisions.
German Children's Cancer Center Aims to Expand Global Access to Methylation-Based Tumor Classifier
Premium
The program will provide funding and expertise to clinics in low-income countries to run methylation array-based assays to classify central nervous system tumors in children.
Ampel BioSolutions Developing Molecular Test to Predict Kidney Damage in Lupus Nephritis Patients
Premium
The test may also be able to identify patients who are most likely to respond to the 45 different drugs for lupus nephritis that are in clinical trials.